Skip to main content
Log in

Gastrointestinal Physiological Changes and Their Relationship to Weight Loss Following the POSE Procedure

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Primary Obesity Surgery Endolumenal (POSE) is a novel bariatric endoscopic procedure that has been shown to reduce weight safely through 12 months. The study investigated potential mechanisms of weight loss following POSE.

Methods

Patients with class I–II obesity received transmural plications in the gastric fundus and distal gastric body. Patients were evaluated at baseline and at 2- and 6-month follow-up with gastric-emptying (GE) scintigraphy, a validated test of intake capacity (kcal) and plasma glucose homeostasis hormones/gastrointestinal peptides. Weight was recorded through 15 months. Mean data and 95 % CIs are reported. Regression modeling assessed variables that influenced total weight loss (%TWL) and excess weight loss (%EWL).

Results

POSE was performed on 18 patients (14 F/4 M); mean age 39 years (34–44), body mass index (BMI, kg/m2) 36 (95 % CI, 35; 37). At 15 months (n = 15), mean TWL was 19.1 ± 6.6 % (15.5; 22.8) and EWL was 63.7 ± 25.1 % (49.8; 77.6). At 2 and 6 months (n = 18), intake capacity decreased significantly from 901 (685; 1117) to 473 (345; 600) and 574 kcal (418; 730), respectively (p < 0.001). At 2 months, GE was delayed but returned to baseline levels at 6 months (n = 18). Glucose/insulin ratio improved (p < 0.05). Postprandial decrease in ghrelin was enhanced (p = 0.03) as well as postprandial increase in PYY (p = 0.001). The best model for EWL prediction 15 months after POSE (R 2: 66 %, p = 0.006) included pre-POSE BMI, post-POSE GE, and postprandial PYY increase.

Conclusions

The POSE procedure was followed by significant sustained weight loss and improved glucose homeostasis and satiation peptide responses. Weight loss following POSE may be mediated through changes in gastrointestinal neuro-endocrine physiology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity. Cochrane Database Syst Rev. 2009;2:Cd003641.

    PubMed  Google Scholar 

  2. Ribaric G, Buchwald JN, McGlennon TW. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg. 2014;m24(3):437–55.

    Article  Google Scholar 

  3. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142(4):621–32.

    Article  PubMed  Google Scholar 

  5. Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149(3):275–87.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Martin M, Beekley A, Kjorstad R, et al. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg Obes Relat Dis. 2010;6(1):8–15.

    Article  PubMed  Google Scholar 

  7. Espinos JC, Turro R, Mata A, et al. Early experience with the Incisionless Operating Platform (IOP) for the treatment of obesity: the Primary Obesity Surgery Endolumenal (POSE) procedure. Obes Surg. 2013;23(9):1375–83.

    Article  CAS  PubMed  Google Scholar 

  8. Lopez-Nava G, Bautistia-Castaño I, Jiminez A, et al. The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis. 2014, in press.

  9. Woods SC. Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake. Am J Physiol Gastrointest Liver Physiol. 2004;286(1):G7–13.

    Article  CAS  PubMed  Google Scholar 

  10. Morton GJ, Meek TH, Schwartz MW. Neurobiology of food intake in health and disease. Nat Rev Neurosci. 2014;15(6):367–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Delgado-Aros S, Cremonini F, Castillo JE, et al. Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology. 2004;126:432–40.

    Article  PubMed  Google Scholar 

  12. Vazquez Roque MI, Camilleri M, Stephens DA, et al. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterol. 2006;131:1717–24.

    Article  CAS  Google Scholar 

  13. Moragas G, Azpirov F, Pavia J, et al. Relations among intragastric pressure, postcibal perception, and gastric emptying. Am J Physiol. 1993;246(6 Part 1):G1112–7.

    Google Scholar 

  14. Gras-Miralles B, Haya JR, Moros JM, et al. Caloric intake capacity as measured by a standard nutrient drink test helps to predict weight loss after bariatric surgery. Obes Surg. 2014;24(12):2138–44.

    Article  PubMed  Google Scholar 

  15. Puigvehi M, Gras-Miralles B, Torra S, et al. Comparison of ad-libitum energy intake and the neuro-endocrine postprandial response as measured during a buffet-type meal and a standardized nutrient drink test. Gastroenterology 2012; 142:S-56.

  16. Torra S, Ilzarbe L, Malagelada JR, et al. Meal size can be decreased in obese subjects through pharmacological acceleration of gastric emptying (The OBERYTH trial). Int J Obes (Lond). 2011;35(6):829–37.

    Article  CAS  Google Scholar 

  17. Meyer-Gerspach AC, Wölnerhanssen B, Beglinger B, et al. Gastric and intestinal satiation in obese and normal weight healthy people. Physiol Behav. 2014;129:265–71.

    Article  CAS  PubMed  Google Scholar 

  18. Camilleri M, Colemont LJ, Phillips SF, et al. Human gastric emptying and colonic filling of solids characterized by a method. Am J Physiol. 1989;257(2 Part 1):G284–90.

    CAS  PubMed  Google Scholar 

  19. Ginsberg GG, Chand B, Cote GA, et al. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011;74(5):943–53.

    Article  PubMed  Google Scholar 

  20. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.

    Article  CAS  PubMed  Google Scholar 

  21. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.

    Article  PubMed  Google Scholar 

  22. Wilson PW, Kannel WB, Silbershatz H, et al. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159(10):1104–9.

    Article  CAS  PubMed  Google Scholar 

  23. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141(11):4255–61.

    CAS  PubMed  Google Scholar 

  24. Cummings DE, Purnell JQ, Frayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50(8):1714–9.

    Article  CAS  PubMed  Google Scholar 

  25. Tschop M, Weyer C, Tataranni PA, et al. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50(4):707–9.

    Article  CAS  PubMed  Google Scholar 

  26. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346(21):1623–30.

    Article  PubMed  Google Scholar 

  27. Morinigo R, Vidal J, Lacy AM, et al. Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg. 2008;247(2):270–5.

    Article  PubMed  Google Scholar 

  28. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, et al. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology. 1985;89:1070–7.

    CAS  PubMed  Google Scholar 

  29. Dockray GJ. Gastrointestinal hormones and the dialogue between gut and brain. J Physiol. 2014;592:2927–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247:401–7.

    Article  PubMed  Google Scholar 

  31. Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003;349(10):941–8.

    Article  CAS  PubMed  Google Scholar 

  32. le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246(5):780–5.

    Article  PubMed  Google Scholar 

  33. Korner J, Inabnet W, Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring). 2006;14(9):1553–61.

    Article  CAS  Google Scholar 

  34. Lakhan SE, Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J Neuroinflamm. 2010;7:37.

    Article  Google Scholar 

  35. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765–9.

    Article  CAS  PubMed  Google Scholar 

  36. Cervero F, Laird JM. Visceral pain. Lancet. 1999;353:2145–8.

    Article  CAS  PubMed  Google Scholar 

  37. Tack J, Demedts I, Dehondt G, et al. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterol. 2002;122:1738–47.

    Article  Google Scholar 

  38. Mearin F, Perez-Oliveras M, Perello A, et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterol. 2005;129:98–104.

    Article  Google Scholar 

Download references

Acknowledgments

We wish to thank Mónica Isart Rueda, director of Laboratory Services at Teknon; Javier Pavia for the assistance with gastric emptying analysis; and Maribel Sánchez for the nutritional support with patients during the study.

Conflict of Interest

Manuscript development was financially supported by USGI Medical, Inc., USA. A. Bronstone is a Scientific Research Writer and J. N. Buchwald is the Director and Chief Scientific Research Writer at Medwrite LLC, a CRO under contract with USGI.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Delgado-Aros.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Espinós, J.C., Turró, R., Moragas, G. et al. Gastrointestinal Physiological Changes and Their Relationship to Weight Loss Following the POSE Procedure. OBES SURG 26, 1081–1089 (2016). https://doi.org/10.1007/s11695-015-1863-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-015-1863-8

Keywords

Navigation